The application of bypassing-agent prophylaxis in haemophilia A patients with inhibitors: a meeting report

被引：10
|
作者：
Valentino, L. A. [1 ,2 ]
Carcao, M. [3 ]
Mathew, P. [4 ]
Leissinger, C. A. [5 ]
Berntorp, E. [6 ]
Blanchette, V. [3 ]
Escuriola-Ettingshausen, C. [7 ]
Ewenstein, B. [8 ]
Ewing, N. [9 ]
Gringeri, A. [10 ]
Hoots, W. K. [11 ]
Negrier, C. [12 ]
机构：
[1] Rush Univ, Med Ctr, Hemophilia & Thrombophilia Ctr, Dept Pediat, Chicago, IL 60612 USA
[2] Rush Univ, Med Ctr, Dept Internal Med, Chicago, IL 60612 USA
[3] Hosp Sick Children, Dept Pediat, Toronto, ON M5G 1X8, Canada
[4] Univ New Mexico, Dept Pediat, Hlth Sci Ctr, Albuquerque, NM 87131 USA
[5] Tulane Univ, Med Ctr, Louisiana Ctr Bleeding & Clotting, New Orleans, LA USA
[6] Malmo Univ Hosp, Dept Coagulat Disorders, Malmo, Sweden
[7] JW Goethe Univ Hosp, Dept Pediat, Franklin, Germany
[8] Baxter Biosci, Westlake Village, CA USA
[9] City Hope Natl Med Ctr, Div Pediat, Duarte, CA 91010 USA
[10] Univ Milan, A Bianchi Bonomi Hemophilia & Thrombosis Ctr, I-20122 Milan, Italy
[11] Univ Texas Med Sch, Dept Pediat, Houston, TX USA
[12] Hop Edouard Herriot, Hemophilia Ctr, Lyon, France
来源：
HAEMOPHILIA | 2009年 / 15卷 / 04期
关键词：
PROTHROMBIN COMPLEX CONCENTRATE; HIGH-RESPONDING INHIBITORS; RECOMBINANT FACTOR-VIIA; IMMUNE TOLERANCE; ACTIVITY FEIBA; INTRACRANIAL HEMORRHAGE; BLEEDING EPISODES; THERAPY; SAFETY; POPULATION;
D O I：
10.1111/j.1365-2516.2008.01953.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：959 / 965
页数：7
相关论文
共 50 条
  • [21] Inhibitors in haemophilia A: the role of VWF/FVIII concentrates - a meeting report
    Kaveri, S.
    Gringeri, A.
    Heisel-Kurth, M.
    Kreuz, W.
    HAEMOPHILIA, 2009, 15 (02) : 587 - 591
  • [22] How I use bypassing therapy for prophylaxis in patients with hemophilia A and inhibitors
    Leissinger, Cindy A.
    Singleton, Tammuella
    Kruse-Jarres, Rebecca
    BLOOD, 2015, 126 (02) : 153 - 159
  • [23] Inhibitors and prophylaxis in paediatric haemophilia patients: Focus on the German experience
    Kurnik, Karin
    Auerswald, Guenter
    Kreuz, Wolfhart
    THROMBOSIS RESEARCH, 2014, 134 : S27 - S32
  • [24] Sequential combined bypassing therapy in haemophilia patients with high titer inhibitors: surgical experience
    Ding, Bingjie
    Song, Xuewen
    Liu, Liu
    Niu, Xiaoying
    Li, Mengjuan
    Zhang, Yuanyuan
    Shao, Shujun
    Xia, Ao
    Liu, Jingyuan
    Zhang, Jing
    Li, Po
    Zhang, Fan
    Liu, Guancong
    Li, Zhehuang
    Zhang, Peng
    Zhou, Hu
    ANNALS OF HEMATOLOGY, 2025,
  • [25] Comparison of Bypassing Agents in Bleeding Reduction in Treatment of Bleeding Episodes in Patients With Haemophilia and Inhibitors
    Golestani, Mina
    Eshghi, Peyman
    Rasekh, Hamid Reza
    Cheraghali, Abdol Majid
    Salamzadeh, Jamshid
    Imani, Ali
    IRANIAN RED CRESCENT MEDICAL JOURNAL, 2014, 16 (12)
  • [26] Global haemostatic assays in monitoring the effect of bypassing agent therapy in haemophilia A patients with inhibitors-an in-vivo prospective crossover study
    Tran, H. T. T.
    Bjornsen, S.
    Ueland, T.
    Pripp, A. H.
    Tjonnfjord, G.
    Holme, P. A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 923 - 923
  • [27] Individualization of bypassing agent treatment for haemophilic patients with inhibitors utilizing thromboelastography
    Young, G.
    Blain, R.
    Nakagawa, P.
    Nugent, D. J.
    HAEMOPHILIA, 2006, 12 (06) : 598 - 604
  • [28] Thrombin generation in plasma of patients with haemophilia A and B with inhibitors: Effects of bypassing agents and antithrombin reduction
    Livnat, Tami
    Sehgal, Alfica
    Qian, Kun
    Huy Van Nguyen
    Madigan, Kate
    Sorensen, Benny
    Kenet, Gili
    BLOOD CELLS MOLECULES AND DISEASES, 2020, 82
  • [29] Emicizumab Prophylaxis in Adolescent/Adult Patients with Haemophilia A Previously Receiving Episodic or Prophylactic Bypassing Agent Treatment: Updated Analyses from the HAVEN 1 Study
    Mancuso, M. E.
    Oldenburg, J.
    Callaghan, M.
    Kruse-Jarres, R.
    Kempton, C.
    Xu, J.
    Catalani, O.
    Asikanius, E.
    Levy, G. G.
    Shima, M.
    Young, G.
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 181 : 127 - 127
  • [30] Surgery with emicizumab prophylaxis for two paediatric patients with severe haemophilia A with inhibitors
    Lockhart, Marguerite
    Tardy-Poncet, Brigitte
    Montmartin, Aurelie
    Noyel, Pauline
    Thouvenin, Sandrine
    Berger, Claire
    PEDIATRIC BLOOD & CANCER, 2021, 68 (07)
12345